RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,750.00
-20.00 (-0.30%)
At close: Feb 13, 2026
Market Cap58.50B +25.9%
Revenue (ttm)134.21B +4.7%
Net Income4.89B
EPS564.30
Shares Out8.67M
PE Ratio11.96
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,943
Average Volume24,920
Open6,770.00
Previous Close6,770.00
Day's Range6,660.00 - 6,780.00
52-Week Range4,765.00 - 9,130.00
Beta0.53
RSI47.71
Earnings Daten/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements